These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 970124)

  • 1. Studies of transitional cell tumours of the bladder. Prognosis and causes of death.
    Sjolin KE; Nyholm K; Trautner K
    Acta Pathol Microbiol Scand A; 1976 Sep; 84(5):361-74. PubMed ID: 970124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis.
    Collan Y; Mäkinen J; Heikkinen A
    Eur Urol; 1979; 5(5):311-8. PubMed ID: 446506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer.
    Kakizoe T; Matsumoto K; Nishio Y; Kishi K
    J Urol; 1984 Mar; 131(3):467-72. PubMed ID: 6699986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
    McKenney JK; Amin MB; Young RH
    Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
    Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
    J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of patients less than 40 years old with bladder tumors.
    Kurz KR; Pitts WR; Vaughan ED
    J Urol; 1987 Mar; 137(3):395-7. PubMed ID: 3820365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading.
    Gilbert HA; Logan JL; Kagan AR; Friedman HA; Cove JK; Fox M; Muldoon TM; Lonni YW; Rowe JH; Cooper JF; Nussbaum H; Chan P; Rao A; Starr A
    J Urol; 1978 Apr; 119(4):488-92. PubMed ID: 650752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic aspects of the morphological signs of bladder cancer].
    Ermilova VD; Mustia AI; Figurin KM
    Arkh Patol; 1994; 56(5):65-9. PubMed ID: 7695498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic correlation of morphometric values with survival in invasive transitional cell carcinoma of the bladder.
    Portillo JA; Val-Bernal JF; Garijo MF; Buelta L; Gutiérrez JL
    Br J Urol; 1992 Dec; 70(6):628-33. PubMed ID: 1486389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 11. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading in superficial bladder cancer. (1). Morphological criteria.
    Pauwels RP; Schapers RF; Smeets AW; Debruyne FM; Geraedts JP
    Br J Urol; 1988 Feb; 61(2):129-34. PubMed ID: 3349277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report.
    Pocock RD; Ponder BA; O'Sullivan JP; Ibrahim SK; Easton DF; Shearer RJ
    Br J Urol; 1982 Dec; 54(6):711-5. PubMed ID: 7150929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent FGFR3 mutations in urothelial papilloma.
    van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
    J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverted papilloma of the urinary tract: histogenesis, recurrence and associated malignancy.
    Renfer LG; Kelley J; Belville WD
    J Urol; 1988 Oct; 140(4):832-4. PubMed ID: 3418815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
    Jordan AM; Weingarten J; Murphy WM
    Cancer; 1987 Dec; 60(11):2766-74. PubMed ID: 3677010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.